Live Geos:
https://partners.subjectwell.com/publishers/geos_report/7ed686a8-b736-4a6e-b098-f188e041530b
Age Range: 18+
Gender: All
*ALL COPY AND CREATIVES MUST BE SUBMITTED TO
[email protected] PRIOR TO GOING LIVE FOR APPROVAL**
Study Description:
This study is testing an investigational oral medication for patients with both high blood pressure and chronic kidney disease (CKD). You will receive daily doses of either the study medication or a placebo. You will not know which medication type you are receiving, but you will take the study medication or placebo every day for 3 months. In addition, you will be given the option to continue taking your current medication for chronic kidney disease (if applicable), or the study sponsor will provide you with an FDA-approved medication for CKD to take alongside the study medication or placebo. Additional procedures include physical exam, laboratory testing (blood and urine), and electrocardiogram (ECG). Total participation will last approximately 4.5 months and would include 9 doctor’s visits throughout the study. Eligibility for the study will be determined by the study doctor following one or more in-person screening visits to the clinic. Trial-related procedures and study medication will be provided at no cost.
Qualifications:
- Cannot be in stage 4 (eGFR 15-29)
- Must be on blood pressure medication and have it still be high
- Cannot have had a heart attach, stroke, or mini-stroke (TIA) in last six months